SCHEMBL5159485

SCHEMBL5159485

Cc1ccc(P(C)(=O)c2ccccc2)cc1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.85
ESR1 P03372 1/20 0.64
LMNA P02545 6/20 0.52
TSHR P16473 2/20 0.52
ALOX12 P18054 1/20 0.48
ACHE P22303 1/20 0.48
GAA P10253 2/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPT P10636 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CA2 P00918 1/20 0.44
CA4 P22748 1/20 0.44
CA5A P35218 1/20 0.44
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
PTGS2 P35354 1/20 0.42
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Toluene SCHEMBL27848238 0.92 HPGD (0.71) HPGDESR1LMNATSHRALOX12
SCHEMBL1727115 0.92 HPGD (1.00) HPGDESR1LMNATSHRACHE
SCHEMBL115791 0.87 ESR1 (0.71) HPGDESR1TSHRALOX12GAA
SCHEMBL27664138 0.85 HPGD (0.61) HPGDESR1LMNATSHRALOX12
SCHEMBL83200 0.85 HPGD (0.61) HPGDESR1LMNATSHRALOX12
SCHEMBL17928368 0.85 HPGD (0.61) HPGDESR1LMNATSHRALOX12
SCHEMBL4402281 0.85 HPGD (0.61) HPGDESR1LMNATSHRALOX12
SCHEMBL4403188 0.85 HPGD (0.61) HPGDESR1LMNATSHRALOX12
SCHEMBL25435946 0.84 ESR1 (0.68) HPGDESR1TSHRALOX12GAA
SCHEMBL30529850 0.83 HPGD (0.58) HPGDESR1LMNATSHRALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017144393-A1 2-SUBSTITUTED 5-(PHENYL)-1,2-DIHYDRO-3H-3-BENZAZEPINE-3-CARBOXAMIDE DERIVATIVES AS BRD4 INHIBITORS FOR THE TREATMENT OF CANCER BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-08-31 WO disclosed
EP-1751170-A1 CHIRAL PHOSPHORUS COMPOUNDS UNIVERSITY COLLEGE DUBLIN (IE) 2007-02-14 EP disclosed
WO-2005118603-A1 CHIRAL PHOSPHORUS COMPOUNDS UNIVERSITY COLLEGE DUBLIN (IE) 2005-12-15 WO disclosed